FOUNTAIN THERAPEUTICS, INC.

Profile

Company Names

FOUNTAIN THERAPEUTICS, INC.

Addresses

681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA 94080

953 INDIANA ST., SAN FRANCISCO, CA 94107

C/O MBCBIOLABS, 953 INDIANA STREET, SAN FRANCISCO, CA 94107

1029 CATHCART WAY, STANFORD, CA 94305

Phone Numbers

628-264-9053
650-856-1971

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$26,864,167.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2021-11-16 
$15,864,168.00 
$15,864,168.00 
$0.00 
Equity 
2
2020-02-12 
$5,999,999.00 
$5,999,999.00 
$0.00 
Equity 
1
2018-05-04 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOHN 
 
DIMOS 
EXECUTIVE OFFICER, DIRECTOR
FOUNTAIN THERAPEUTICS, INC.
WILLIAM 
 
GREENE 
EXECUTIVE OFFICER, DIRECTOR
NEOVISTA INC   |  ENDOGASTRIC SOLUTIONS INC   |  MPM BIOVENTURES V, L.P.   |  THERACLONE SCIENCES, INC.   |  ICONIC THERAPEUTICS INC   |  FOUNTAIN THERAPEUTICS, INC.   |  BANYAN INFRASTRUCTURE CORP   |  AEOVIAN PHARMACEUTICALS, INC.
ASHISH 
 
KHANNA 
DIRECTOR
NAUREX INC.   |  SUTROVAX, INC.   |  APTINYX INC.   |  BOLT BIOTHERAPEUTICS, INC.   |  FOUNTAIN THERAPEUTICS, INC.
ALEX 
 
MORGAN 
DIRECTOR
COLORESCIENCE INC   |  ARTRENDEX, INC.   |  HELLO HEART INC.   |  SYNCHRON, INC.   |  PRELLIS BIOLOGICS, INC   |  FOUNTAIN THERAPEUTICS, INC.   |  KRNL, INC.   |  GATHER HEALTH PRIMARY CARE, INC.   |  VIOME LIFE SCIENCES, INC.   |  VIVODYNE, INC.   |  OPENTRONS LABWORKS INC.   |  FAETH THERAPEUTICS, INC.
THOMAS 
 
RANDO 
EXECUTIVE OFFICER, DIRECTOR
FOUNTAIN THERAPEUTICS, INC.
THOMAS 
A. 
RANDO 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
FOUNTAIN THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-12-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-11-16 
2020-02-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-02-12 
2018-09-18
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-04 
2018-05-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-04 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#